Home | Welcome to Contract Pharma   
Last Updated Monday, September 1 2014
Print

Bioserv Appoints Pharma Technologies SVP



Published April 21, 2014
Related Searches: Development Pharma cGMP Manufacturing

Jay Schrier, Ph.D., has been appointed senior vice president of Pharmaceutical Technologies at Bioserv Corp.

Dr. Schrier has more than 25 years of analytical and pharmaceutical development experience and has helped create numerous cGMP-compliant analytical and pharmaceutical development departments within the pharma industry. Prior to joining the company, he was senior director of pharmaceutical development at Pacira Pharmaceuticals.

Al Hansen, chairman and chief executive officer of Bioserv Corp. and managing partner at KESA Partners, said, “We are excited to welcome someone with Dr. Schrier’s outstanding qualifications and leadership skills to our growing executive team at Bioserv. His development expertise will result in significant value creation for our manufacturing clients. Dr. Schrier will provide expertise to our clients to enable them to manufacture their products to high quality standards but in a cost-effective manner.”



blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On